| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
AZD1981
|
802904-66-1 |
AZD1981
|
4-(乙酰氨基)-3-[(4-氯苯基)硫代]-2-甲基-1H-吲哚-1-乙酸
|
C25H28F3N5O6S |
583.57993 | |
|
ATB 346
|
1226895-20-0 |
ATB 346
|
ATB346;ATB 346;ABT-346 抑制剂;CS-1282;4-CARBAMOTHIOYLPHENYL 2-(6-METHOXYNAPHTHALEN-2-YL)PROPANOATE
|
C21H19NO3S |
365.44546 | |
|
CAY10603
|
1045792-66-2 |
CAY10603
|
N-[4-[3-[[[7-(羟基氨基)-7-氧代庚基]氨基]羰基]-5-异恶唑基]苯基]氨基甲酸叔丁酯;CAY10603;CAY-10603;CAY 10603.
|
C22H30N4O6 |
446.4968 | |
|
Venlafaxine Related Compound A (10 mg) (1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride)
|
93413-90-2 |
盐酸文拉法辛杂质D
|
N-去甲基盐酸文拉法辛 (文拉法辛杂质D);VENLAFAXINE-3;文拉法辛EP杂质D HCL;盐酸文拉法辛杂质D;文拉法辛杂质D;万拉法新相关物质A;1-[1-(4-甲氧基苯基)-2-(甲基氨基)乙基]环己醇盐酸盐;文拉法辛EP杂质D
|
C17H27NO2 |
277.40178 | |
|
AT13148
|
1056901-62-2 |
AT13148
|
AT-13148;AT 13148;(+)-(S)-2-氨基-1-(4-氯苯基)-1-[4-(1H-吡唑-4-基)苯基]乙醇;CS-1252
|
C17H16ClN3O |
313.78144 | |
|
5'-O-[(4-Cyanophenyl(methyl]-8-[[(3,4-dichlorophenyl(methyl]amino]-adenosine
|
1134156-31-2 |
VER 155008
|
CS-1647;VER 155008;VER-155008;VER155008;5'-O-[(4-氰基苯基(甲基]-8-[[(3,4-二氯苯基(甲基]氨基]腺苷
|
C25H23Cl2N7O4 |
556.40062 | |
|
ZM 323881 hydrochloride
|
193000-39-4 |
ZM323881HCL
|
Phenol, 4-fluoro-2-methyl-5-[[7-(phenylmethoxy)-4-quinazolinyl]amino]-, hydrochloride (1:1);ZM 323881 HCl, >=99%
|
C22H19ClFN3O2 |
411.8565632 | |
|
MMP-2/MMP-9 INHIBITOR IV
|
292605-14-2 |
SB-3CT
|
[[(4-苯氧基苯基)磺酰基]甲基]噻丙环
|
C15H14O3S2 |
306.39986 | |
|
FIPI
|
939055-18-2 |
FIPI
|
FIPI;FIPI HYDROCHLORIDE;N-[2-[4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethy]-5-fluoro-1H-indole-2-carboxamide hydrochloride;5-fluoro-N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-1H-indole-2-carboxamide;5-Fluoro-2-Indolyl des-Chlorohalopemide;N-[2-[4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-5-fluoro-1H-indole-2-carboxamide
|
C23H24FN5O2 |
421.4673632 | |
|
ent Naxagolide Hydrochloride
|
100935-99-7 |
那高利特盐酸盐
|
entNaxagolide Hydrochloride;trans-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol hydrochloride
|
C15H21NO2.ClH |
283.797 | |
|
JNJ7777120
|
459168-41-3 |
JNJ7777120
|
(5-氯-1H-吲哚-2-基((4-甲基哌嗪-1-基(甲酮;1-[(5-氯-1H-吲哚-2-基(羰基]-4-甲基哌嗪;CS-593;JNJ-7777120;JNJ7777120
|
C14H16ClN3O |
277.753 | |
|
(E)-3-(3-bromo-4,5-dihydroxyphenyl)-N-(3,4,5-trihydroxybenzyl)prop-2-enethioamide
|
1384426-12-3 |
NT-157
|
NT-157;NT 157;TYRPHOSTIN NT157;NT-157;(E)-3-(3-溴-4,5-二羟苯基)-N-(3,4,5-三羟基苄基)丙-2-烯硫代酰胺;CS-2283;NT157;NT 157;(2E)-3-(3-溴-4,5-二羟基苯基)-N-[(3,5-三羟基苯基)甲基]-2-硫代丙烯酰胺
|
C16H14BrNO5S |
412.25506 | |
|
VidofludiMus
|
717824-30-1 |
VIDOFLUDIMUS(4SC-101; SC12267)
|
|
C20H18FNO4 |
355.359623 | 615-418-4 |
|
A 77-01
|
607737-87-1 |
A 77-01
|
4-[3-(6-甲基-2-吡啶基)-1H-吡唑-4-基]喹啉
|
C18H14N4 |
286.33 | |
|
ITD-1
|
1099644-42-4 |
ITD 1
|
ETHYL 4-{[1,1'-BIPHENYL]-4-YL}-2,7,7-TRIMETHYL-5-OXO-1,4,6,8-TETRAHYDROQUINOLINE-3-CARBOXYLATE;ITD-1;4-[1,1'-Biphenyl]-4-yl-1,4,5,6,7,8-hexahydro-2,7,7-trimethyl-5-oxo-3-quinolinecarboxylic acid ethyl ester;AOB6123;SCHEMBL3239096
|
|||
|
Prinaberel
|
524684-52-4 |
普林贝瑞
|
2-(3-氟-4-羟基苯基)-7-乙烯基-1,3-苯并恶唑-5-醇;普林贝瑞
|
C15H10FNO3 |
271.24 | |
|
UK-383367
|
348622-88-8 |
UK 383367
|
5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺;UK-383367 (UK 383367)
|
C15H24N4O4 |
324.37546 | |
|
NS 6180
|
353262-04-1 |
NS 6180
|
4-[[3-(三氟甲基)苯基]甲基]-2H-1,4-苯并噻嗪-3(4H)-酮
|
C16H12F3NOS |
323.33279 | |
|
GSK1014802(CNV1014802)
|
934240-30-9 |
GSK1014802
|
RAXATRIGINE;CNV1014802;GSK-1014802;GSK-1014802;RAXATRIGINE;CS-657;CNV-1014802;RAXATRIGINE;VIXOTRIGINE;BIIB074
|
C18H19FN2O2 |
314.354063 | |
|
UNC0379
|
1620401-82-2 |
UNC0379
|
CS-1767;6,7-二甲氧基-2-(1-吡咯烷基)-N-[5-(1-吡咯烷基)戊基]-4-喹唑啉胺;UNC 0379;UNC-0379
|
C23H35N5O2 |
413.57 |
药智官方微信
药智官方微博
